Mometasone/Formoterol (Dulera) for Asthma
A combination of the corticosteroid mometasone furoate (Asmanex) and the long-acting beta2-agonist
(LABA) formoterol (Foradil) has become available in a
single metered-dose inhaler (Dulera – Schering) for
treatment of asthma in patients ≥12 years old. It is the
third corticosteroid/LABA combination inhaler to
become available for this indication in the US. None of
these combinations should be used for initial treatment
of asthma or for acute treatment of asthma symptoms....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Mometasone/Formoterol (Dulera) for Asthma
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1349
Article Code: 1349c
Date: October 18, 2010
Volume: 52
Pages: 83-84
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1349
Article Code: 1349c
Date: October 18, 2010
Volume: 52
Pages: 83-84
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)
